Trademark: 97484095
Status Date
Tuesday, February 28, 2023
Filing Date
Thursday, June 30, 2022
Abandoned Date
Friday, February 17, 2023
5 Biopharmaceutical preparations; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Cell therapies for use in oncology, immunology, and immuno-oncology; Therapeutic agents for targeting tumors; Biological components, namely, genetically engineered T-cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immuno-oncology; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use
Mar 1, 2023
Abandonment Notice E-Mailed - Failure To Respond
Feb 28, 2023
Abandonment Notice Mailed - Failure To Respond
Feb 28, 2023
Abandonment - Failure To Respond Or Late Response
Aug 16, 2022
Notification Of Non-Final Action E-Mailed
Aug 16, 2022
Non-Final Action E-Mailed
Aug 16, 2022
Non-Final Action Written
Aug 16, 2022
Assigned To Examiner
Jul 20, 2022
New Application Office Supplied Data Entered
Jul 4, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24